SPARCL1 and metabolic dysfunction-associated steatotic liver disease: Additionally, numerous studies have found that the majority of lncRNAs accelerate or attenuate the progression of NAFLD primarily by sponging microRNAs, including CCAT1, PVT1, lnc-SPARCL1-1:2, UC.372, MALAT1, UC.333, and NEAT1 [40,41,42,43,44].